Unknown PHASE2/PHASE3 INTERVENTIONAL 3-arm NCT01865266

The Effect of Ulinastatin on Bronchoalveolar Lavage Fluid of Inflammatory Factors in Patients With Ventilator-associated Pneumonia

Sponsor: RenJi Hospital

Conditions Mechanical Ventilation Complication Ventilator-associated Bacterial Pneumonia

Interventions Ulinaststin for injection placebo

Updated 5 times since 2017 Last updated: May 29, 2013 Started: Jan 31, 2014 Primary completion: Dec 31, 2015 Completion: Jun 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Mechanical Ventilation Complication and Ventilator-associated Bacterial Pneumonia, this trial is ongoing. The trial is conducted by RenJi Hospital and has accumulated 5 data snapshots since 2014. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2_PHASE3

First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

RenJi Hospital
Ruijin Hospital
Shanghai Jiao Tong University School of Medicine
Shanghai Minhang Central Hospital

Data source: Shanghai Minhang Central Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China